Dr. Douglas McKay Wallace, MD

Dr. Wallace practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Wallace's NPI, 1013058932, was assigned on February 12, 2007. Dr. Wallace graduated from University of Miami, Miller School of Medicine in 2002. Dr. Wallace holds Florida license ME94643.

Dr. Wallace's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Wallace's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wallace practices. Vendor and product names are available with a free account.

Neurology is Dr. Wallace's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Wallace is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Wallace is licensed in Florida.

Dmand AI lists hypersomnia, restless legs syndrome and sleep apnea among the conditions Dr. Wallace treats.

CMS data shows 43 Medicare services from Dr. Wallace across 2 procedure codes in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $3,626 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 40 Medicare patients who saw Dr. Wallace in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wallace's median patient age at 59, with 35% women.

In 2024, Dr. Wallace wrote 135 Medicare Part D claims for 25 patients. 93% of them were for generic drugs. CMS names the drug for 107 of them, across 5 drugs with 11 or more claims each, at $1,022 in total drug cost. In 2023, CMS named 106 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Wallace for performance year 2024, reported as part of a group. Dr. Wallace accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wallace as offering telehealth.

Dmand AI links 62 papers to Dr. Wallace, published from 2005 to 2023. 2020 was the busiest year, with 8. The most frequent topics are Sleep Apnea, Obstructive, Sleep Initiation and Maintenance Disorders and Continuous Positive Airway Pressure. Dr. Wallace has published most often in J Clin Sleep Med. Dr. Wallace's most frequent co-authors are Alberto Rafael Ramos, MD, Shirin Shafazand, MD and Alexandre R. Abreu, MD.

CMS Open Payments shows 124 general payments to Dr. Wallace from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Eisai Inc. paid the most, $4,890.

Dr. Wallace graduated from University of Miami, Miller School of Medicine in 2002. Dr. Wallace is a member of AAN and AASM.

Dr. Wallace is in network with 11 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.